The Board of Directors of the Company at its meeting held today, i.e. August 12, 2025, have inter-alia, considered and approved Standalone Un-Audited Financial Results for quarter ended ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Chemiesynth (Vapi) Ltd, at its meeting on August 12, 2025, approved the standalone unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). Revenue from operations rose to ₹397.46 lakhs from ₹285.24 lakhs in Q1 FY25, a growth of about 39%. However, the company slipped deeper into a loss of ₹(45.63) lakhs versus ₹(24.35) lakhs a year ago, as expenses climbed sharply to ₹443.09 lakhs. EPS stood at ₹(1.49) versus ₹(0.79) earlier. The statutory auditor issued an unqualified limited review report. The Board also appointed Mr. Nitin Sarfare as Secretarial Auditor for 5 years and reappointed M/s Purvi Gandhi and Associates as Internal Auditor. The 39th AGM is scheduled for September 30, 2025.
Despite strong revenue growth, rising costs (especially other expenses and finance costs) widened losses, which is a concern for shareholders. Stock price may react negatively to the deeper quarterly loss, though top-line momentum is a positive sign.